Viewing Study NCT07037160


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2025-12-26 @ 12:45 AM
Study NCT ID: NCT07037160
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-25
First Post: 2025-06-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Effectiveness of Foam RE and KE for Urinary Incontinence in Postpartum Women With Diastasis Recti
Sponsor: Superior University
Organization:

Study Overview

Official Title: Effectiveness of Foam Rolling Exercise and Kegel Exercise for Urinary Incontinence in Postpartum Women With Diastasis Recti
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of the study will be to assess the efficacy of foam rolling alone and combination treatment of foam rolling and Kegel exercises in alleviating urinary incontinence among postpartum women with diastasis recti.

The data will be collected from 60 enrolled postpartum females with diastasis recti to evaluate the effectiveness of foam rolling alone compared to foam rolling and Kegel exercises in improving urinary incontinence. The data will be collected using urogenital distress inventory (UDI).
Detailed Description: Urinary incontinence is a common issue among postpartum women, often linked to diastasis recti, which weakens core and pelvic floor muscles. Despite its prevalence, effective combined treatment approaches remain limited. Foam rolling may enhance muscle function, while Kegel exercises strengthen the pelvic floor. This study investigates their combined effectiveness in managing urinary incontinence among postpartum women with diastasis recti, compared to Kegel exercises alone.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: